Antibacterial Agents Against Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Resistant Enterococci (VRE)
Miguel O. Mitchell.
The emergence of nosocomial infections caused by methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE) has prompted research directed at the development of novel antibacterial agents to treat these diseases. This review will examine the literature on anti-MRSA and anti-VRE antibacterial research published between 2001 and October 2006.
Keywords: Chloroorienticin B, quinolone, natural products, linezolid, bacterial cell wall
Rights & PermissionsPrintExport